Axsome Therapeutics Inc Shares Fall 1.2% Below Previous 52-Week Low - Market Mover

The shares fell 1.2% lower than its previous 52-week low of $53.63, with trading volume lower than its 30 day average

Apr 07, 2021 by Kwhen Finance Editors

Axsome Therapeutics Inc Shares Fall 1.2% Below Previous 52-Week Low - Market Mover
Axsome Therapeutics Inc shares closed 1.2% lower than its previous 52 week low, giving the company a market cap of $2B. The stock is currently down 33.6% year-to-date, down 7.1% over the past 12 months, and up 432.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 2.0%.

Trading Activity

  • Trading volume this week was 30.8% lower than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.
  • The stock closed at 3.5% lower than its 5-day moving average, 11.4% lower than its 20-day moving average, and 26.2% lower than its 90-day moving average.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Axsome Therapeutics Inc-2.0-33.6-7.1-51.1-0.0
Dow Jones Industrial Average0.810.145.9-0.149.9
S&P 500 Index0.79.651.5-0.052.9
Health Care1.02.927.4-2.529.5

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -166.6%
  • The company's stock price performance over the past 12 months lags the peer average by -107.3%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Axsome Therapeutics IncAXSM0-33.6-7.1-51.1-0.0
Peer AvgN/A050.596.2-27.3188.2
Ocular Therapeutix IncOCUL0-19.2219.3-30.6254.4
OncoCyte CorpOCX0123.4123.4-20.1356.5
Oragenics Inc.OGEN097.742.1-58.4141.7

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: